Difference between revisions of "Template:Team:TU Eindhoven/Policy Practices Timeline HTML"
Line 56: | Line 56: | ||
Week 29 | Week 29 | ||
</h4> | </h4> | ||
− | <h3> - | + | <h3> - The National Institute for Public Health and the Environment (RIVM)</h3> |
<br /> | <br /> | ||
<ul class="activiteitlijst"> | <ul class="activiteitlijst"> | ||
− | <li><span class="activiteit">We had an appointment with Claudette de Vries and Robert Geertsma of the RIVM. | + | <li><span class="activiteit">We had an appointment with Claudette de Vries and Robert Geertsma of the RIVM.We discussed the directives and regulations of new medicines, medical devices and in vitro diagnostics</span></li> |
− | We discussed the directives and regulations of new medicines, medical devices and in vitro diagnostics</span></li> | + | |
<li><span class="activiteit">We met Eric van den Akker of the GMO bureau (RIVM) discussing rules and regulations of the introduction of GMOs in the environment</span></li> | <li><span class="activiteit">We met Eric van den Akker of the GMO bureau (RIVM) discussing rules and regulations of the introduction of GMOs in the environment</span></li> | ||
</ul> | </ul> |
Revision as of 08:31, 20 July 2015
Timeline policy practices
Week 22
- Meetings
- Meeting up with Bart Wijnhoven and discussing the TU/e matching days
- A first meeting with all iGEM teams of the Netherlands in collaboration with the National Institute for Public Health and the Environment (RIVM) and the Rathenau Institute
Week 23 &
- TU/e matching days
- Introducing new students to synthetic biology
Week 26
- mr. drs. Virgil Rerimassie of the Rathenau Institute
- A promising brainstorm session with mr drs. Virgil Rerimassie from the Rathenau Institute discussing policy practices in relation to our project
Week 27, 28 & 29
- emails, emails, emails
- Making (internet) contact with different stakeholders
- Brainstorming about application scenarios
Week 29
- The National Institute for Public Health and the Environment (RIVM)
- We had an appointment with Claudette de Vries and Robert Geertsma of the RIVM.We discussed the directives and regulations of new medicines, medical devices and in vitro diagnostics
- We met Eric van den Akker of the GMO bureau (RIVM) discussing rules and regulations of the introduction of GMOs in the environment